Anti-inflammatory Therapeutics Market in UK - Industry Outlook and Forecast 2020-2026

April 2020 | 106 pages | ID: ACE1C13BE207EN
Market Monitor Global

Abstracts

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

This report contains market size and forecasts of Anti-inflammatory Therapeutics in UK, including the following market information:
UK Anti-inflammatory Therapeutics Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in UK Anti-inflammatory Therapeutics Market 2019 (%)
The global Anti-inflammatory Therapeutics market was valued at 100870 million in 2019 and is projected to reach US$ 126610 million by 2026, at a CAGR of 5.8% during the forecast period. While the Anti-inflammatory Therapeutics market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Anti-inflammatory Therapeutics businesses, with lots of challenges and uncertainty faced by many players of Anti-inflammatory Therapeutics in UK.
This report also analyses and evaluates the COVID-19 impact on Anti-inflammatory Therapeutics market size in 2020 and the next few years in UK

Total Market by Segment:

UK Anti-inflammatory Therapeutics Market, By Type, 2015-2020, 2021-2026 ($ millions)
UK Anti-inflammatory Therapeutics Market Segment Percentages, By Type, 2019 (%)

• Anti-inflammatory Biologics
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others
• On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

UK Anti-inflammatory Therapeutics Market, By Application, 2015-2020, 2021-2026 ($ millions)
UK Anti-inflammatory Therapeutics Market Segment Percentages, By Application, 2019 (%)

• Arthritis
• Respiratory Diseases
• Dermatology
• Gastroenterology
• Others
• Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Anti-inflammatory Therapeutics Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)
Total Anti-inflammatory Therapeutics Market Competitors Revenues Share in UK, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:

• AbbVie
• Johnson & Johnson
• Amgen Inc
• AstraZeneca PLC
• Pfizer, Inc
• Novartis
• Roche
• Merck
• Sanofi
• GlaxoSmithKline
• Sun Pharmaceutical Industries Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 COVID-19 Impact: UK Anti-inflammatory Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 UK ANTI-INFLAMMATORY THERAPEUTICS OVERALL MARKET SIZE

2.1 UK Anti-inflammatory Therapeutics Market Size: 2020 VS 2026
2.2 UK Anti-inflammatory Therapeutics Revenue, Prospects & Forecasts: 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Anti-inflammatory Therapeutics Players in UK (including Foreign and Local Companies)
3.2 Top UK Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 UK Anti-inflammatory Therapeutics Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in UK, by Revenue in 2019
3.5 UK Manufacturers Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in UK
  3.6.1 List of UK Tier 1 Anti-inflammatory Therapeutics Companies
  3.6.2 List of UK Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - UK Anti-inflammatory Therapeutics Market Size Markets, 2020 & 2026
  4.1.2 Anti-inflammatory Biologics
  4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  4.1.4 Corticosteroids
  4.1.5 Others
4.2 By Type - UK Anti-inflammatory Therapeutics Revenue & Forecasts
  4.2.1 By Type - UK Anti-inflammatory Therapeutics Revenue, 2015-2020
  4.2.2 By Type - UK Anti-inflammatory Therapeutics Revenue, 2021-2026
  4.2.3 By Type - UK Anti-inflammatory Therapeutics Revenue Market Share, 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - UK Anti-inflammatory Therapeutics Market Size, 2020 & 2026
  5.1.2 Arthritis
  5.1.3 Respiratory Diseases
  5.1.4 Dermatology
  5.1.5 Gastroenterology
  5.1.6 Others
5.2 By Application - UK Anti-inflammatory Therapeutics Revenue & Forecasts
  5.2.1 By Application - UK Anti-inflammatory Therapeutics Revenue, 2015-2020
  5.2.2 By Application - UK Anti-inflammatory Therapeutics Revenue, 2021-2026
  5.2.3 By Application - UK Anti-inflammatory Therapeutics Revenue Market Share, 2015-2026

6 PLAYERS PROFILES

6.1 AbbVie
  6.1.1 AbbVie Corporate Summary
  6.1.2 AbbVie Business Overview
  6.1.3 AbbVie Anti-inflammatory Therapeutics Major Product Offerings
  6.1.4 AbbVie Revenue in UK (2015-2020)
  6.1.5 AbbVie Key News
6.2 Johnson & Johnson
  6.2.1 Johnson & Johnson Corporate Summary
  6.2.2 Johnson & Johnson Business Overview
  6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Major Product Offerings
  6.2.4 Johnson & Johnson Revenue in UK (2015-2020)
  6.2.5 Johnson & Johnson Key News
6.3 Amgen Inc
  6.3.1 Amgen Inc Corporate Summary
  6.3.2 Amgen Inc Business Overview
  6.3.3 Amgen Inc Anti-inflammatory Therapeutics Major Product Offerings
  6.3.4 Amgen Inc Revenue in UK (2015-2020)
  6.3.5 Amgen Inc Key News
6.4 AstraZeneca PLC
  6.4.1 AstraZeneca PLC Corporate Summary
  6.4.2 AstraZeneca PLC Business Overview
  6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Major Product Offerings
  6.4.4 AstraZeneca PLC Revenue in UK (2015-2020)
  6.4.5 AstraZeneca PLC Key News
6.5 Pfizer, Inc
  6.5.1 Pfizer, Inc Corporate Summary
  6.5.2 Pfizer, Inc Business Overview
  6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Major Product Offerings
  6.5.4 Pfizer, Inc Revenue in UK (2015-2020)
  6.5.5 Pfizer, Inc Key News
6.6 Novartis
  6.6.1 Novartis Corporate Summary
  6.6.2 Novartis Business Overview
  6.6.3 Novartis Anti-inflammatory Therapeutics Major Product Offerings
  6.6.4 Novartis Revenue in UK (2015-2020)
  6.6.5 Novartis Key News
6.7 Roche
  6.6.1 Roche Corporate Summary
  6.6.2 Roche Business Overview
  6.6.3 Roche Anti-inflammatory Therapeutics Major Product Offerings
  6.4.4 Roche Revenue in UK (2015-2020)
  6.7.5 Roche Key News
6.8 Merck
  6.8.1 Merck Corporate Summary
  6.8.2 Merck Business Overview
  6.8.3 Merck Anti-inflammatory Therapeutics Major Product Offerings
  6.8.4 Merck Revenue in UK (2015-2020)
  6.8.5 Merck Key News
6.9 Sanofi
  6.9.1 Sanofi Corporate Summary
  6.9.2 Sanofi Business Overview
  6.9.3 Sanofi Anti-inflammatory Therapeutics Major Product Offerings
  6.9.4 Sanofi Revenue in UK (2015-2020)
  6.9.5 Sanofi Key News
6.10 GlaxoSmithKline
  6.10.1 GlaxoSmithKline Corporate Summary
  6.10.2 GlaxoSmithKline Business Overview
  6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Major Product Offerings
  6.10.4 GlaxoSmithKline Revenue in UK (2015-2020)
  6.10.5 GlaxoSmithKline Key News
6.11 Sun Pharmaceutical Industries Ltd
  6.11.1 Sun Pharmaceutical Industries Ltd Corporate Summary
  6.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Business Overview
  6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Major Product Offerings
  6.11.4 Sun Pharmaceutical Industries Ltd Revenue in UK (2015-2020)
  6.11.5 Sun Pharmaceutical Industries Ltd Key News
6.12 TEVA
  6.12.1 TEVA Corporate Summary
  6.12.2 TEVA Anti-inflammatory Therapeutics Business Overview
  6.12.3 TEVA Anti-inflammatory Therapeutics Major Product Offerings
  6.12.4 TEVA Revenue in UK (2015-2020)
  6.12.5 TEVA Key News

7 KEY MARKET TRENDS & INFLUENCES 2021-2026

7.1 PESTLE Analysis for UK Anti-inflammatory Therapeutics Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-inflammatory Therapeutics in UK
Table 2. Top Players in UK, Ranking by Revenue (2019)
Table 3. UK Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2015-2020
Table 4. UK Anti-inflammatory Therapeutics Revenue Share by Companies, 2015-2020
Table 5. UK Anti-inflammatory Therapeutics Sales by Companies, (K Units), 2015-2020
Table 6. UK Anti-inflammatory Therapeutics Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Anti-inflammatory Therapeutics Price (2015-2020) (US$/Unit)
Table 8. UK Manufacturers Anti-inflammatory Therapeutics Product Type
Table 9. List of UK Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of UK Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Anti-inflammatory Therapeutics Revenue in UK (US$, Mn), 2015-2020
Table 12. By Type - Anti-inflammatory Therapeutics Revenue in UK (US$, Mn), 2021-2026
Table 13. By Type - Anti-inflammatory Therapeutics Sales in UK (K Units), 2015-2020
Table 14. By Type - Anti-inflammatory Therapeutics Sales in UK (K Units), 2021-2026
Table 15. By Application - Anti-inflammatory Therapeutics Revenue in UK, (US$, Mn), 2015-2020
Table 16. By Application - Anti-inflammatory Therapeutics Revenue in UK, (US$, Mn), 2021-2026
Table 17. By Application - Anti-inflammatory Therapeutics Sales in UK, (K Units), 2015-2020
Table 18. By Application - Anti-inflammatory Therapeutics Sales in UK, (K Units), 2021-2026
Table 19. AbbVie Corporate Summary
Table 20. AbbVie Anti-inflammatory Therapeutics Product Offerings
Table 21. AbbVie Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 22. Johnson & Johnson Corporate Summary
Table 23. Johnson & Johnson Anti-inflammatory Therapeutics Product Offerings
Table 24. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 25. Amgen Inc Corporate Summary
Table 26. Amgen Inc Anti-inflammatory Therapeutics Product Offerings
Table 27. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 28. AstraZeneca PLC Corporate Summary
Table 29. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offerings
Table 30. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 31. Pfizer, Inc Corporate Summary
Table 32. Pfizer, Inc Anti-inflammatory Therapeutics Product Offerings
Table 33. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Anti-inflammatory Therapeutics Product Offerings
Table 36. Novartis Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 37. Roche Corporate Summary
Table 38. Roche Anti-inflammatory Therapeutics Product Offerings
Table 39. Roche Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 40. Merck Corporate Summary
Table 41. Merck Anti-inflammatory Therapeutics Product Offerings
Table 42. Merck Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 43. Sanofi Corporate Summary
Table 44. Sanofi Anti-inflammatory Therapeutics Product Offerings
Table 45. Sanofi Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offerings
Table 48. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 49. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 50. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offerings
Table 51. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 52. TEVA Corporate Summary
Table 53. TEVA Anti-inflammatory Therapeutics Product Offerings
Table 54. TEVA Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-inflammatory Therapeutics Segment by Type
Figure 2. Anti-inflammatory Therapeutics Segment by Application
Figure 3. UK Anti-inflammatory Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Anti-inflammatory Therapeutics Market Size in UK, (US$, Mn): 2020 VS 2026
Figure 6. UK Anti-inflammatory Therapeutics Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2019
Figure 8. By Type - UK Anti-inflammatory Therapeutics Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - UK Anti-inflammatory Therapeutics Market Share, 2015-2026
Figure 10. By Application - Anti-inflammatory Therapeutics Revenue in UK (US$, Mn), 2020 & 2026
Figure 11. By Application - UK Anti-inflammatory Therapeutics Market Share, 2015-2026
Figure 12. PEST Analysis for UK Anti-inflammatory Therapeutics Market in 2020
Figure 13. Anti-inflammatory Therapeutics Market Opportunities & Trends in UK
Figure 14. Anti-inflammatory Therapeutics Market Drivers in UK